Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genetic test for cigarette quitters identified:

This article was originally published in Clinica

Executive Summary

A test to establish how easily a smoker can give up cigarettes may become a reality thanks to the discovery of a genetic change that seems to influence a person's dependence on nicotine. A study of 326 smokers and ex-smokers in Japan found that those lacking one or both copies of the nicotine metabolism gene CYP2A6 are less likely to give up smoking. However, the genetic change was more common in light smokers than heavy smokers. Writing in the July issue of the journal Thorax, the Tokyo University researchers suggest testing for genotype could be useful in efficiently withdrawing patients from cigarettes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel